Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI- or PI-treated patients.

HIV clinical trials - 1 Jan 2000

Maggiolo Franco, Airoldi Monica, Kleinloog Hendrik Daniël, Callegaro Annapaola, Ravasio Veronica, Arici Claudio, Bombana Enrico, Suter Fredy

Abstract excerpt

BACKGROUND: The effect of adherence on the risk of virologic failure and mutations selection was verified in a prospective study. METHOD: At baseline, all patients had a viral load (VL) <50 copies/mL and completed a self-reported questionnaire. Patients were followed for the subsequent 4 months to document virologic rebound (VL > 50 copies/mL). RESULTS: 1,133 patients completed 2,240 questionnaires/follow-up...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to HIV Protease Inhibitors

Share to Patient Compliance

Share to Reverse Transcriptase Inhibitors

Share to Viral Load

Source

Identifiers

PMID: 17956829
DOI: 10.1310/hct0805-282

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI- or PI-treated patients.PMID 17956829Read ↗

Long-term virological outcome and resistance mutations at virological rebound in HIV-infected adults on protease inhibitor-sparing highly active antiretroviral therapy.Semantic proximity Read ↗

Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study.Semantic proximity Read ↗

Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness.Semantic proximity Read ↗

Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure.Semantic proximity Read ↗

Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation.Semantic proximity Read ↗

Modeling the HIV Protease Inhibitor Adherence–Resistance Curve by Use of Empirically Derived EstimatesSemantic proximity Read ↗

Adherence and preexisting major protease inhibitor resistance mutations are associated with virologic failure of a dual-class antiretroviral regimen with inhibitors of HIV-1 viral protease and integrase.Semantic proximity Read ↗

Assessing the impact of adherence to anti-retroviral therapy on treatment failure and resistance evolution in HIV.Semantic proximity Read ↗

Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance.Semantic proximity Read ↗

Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study.Semantic proximity Read ↗

The relationship between resistance and adherence in drug-naive individuals initiating HAART is specific to individual drug classes.Semantic proximity Read ↗

Suboptimal adherence associated with virological failure and resistance mutations to first-line highly active antiretroviral therapy (HAART) in Bangalore, IndiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.